tiprankstipranks
Advertisement
Advertisement

VRTX Stock Latest News

Vertex announces U.S. FDA accepted BLA submission for povetacicept
The FlyVertex announces U.S. FDA accepted BLA submission for povetacicept
3d ago
VRTX
Vertex Pharmaceuticals assumed with a Buy at Truist
PremiumThe Fly
Vertex Pharmaceuticals assumed with a Buy at Truist
8d ago
VRTX
Vertex announces Health Canada acceptance of NDS for suzetrigine
PremiumThe Fly
Vertex announces Health Canada acceptance of NDS for suzetrigine
13d ago
VRTX
Vertex Steps Into Autoimmune Care: Mid-Stage Myasthenia Gravis Trial Shows Growing Pipeline Ambition
PremiumCompany Announcements
Vertex Steps Into Autoimmune Care: Mid-Stage Myasthenia Gravis Trial Shows Growing Pipeline Ambition
16d ago
VRTX
Citizens biotechnology analyst holds analyst/industry conference call
PremiumThe Fly
Citizens biotechnology analyst holds analyst/industry conference call
19d ago
SION
VRTX
Vertex Shareholders Endorse Board, Governance and Equity Plan
PremiumCompany AnnouncementsVertex Shareholders Endorse Board, Governance and Equity Plan
21d ago
8K
VRTX
Palatin Is Betting on the Next Generation of Obesity Drugs (NYSE: PTN)
Premium
TipRanks Newswire
Palatin Is Betting on the Next Generation of Obesity Drugs (NYSE: PTN)
22d ago
NVO
PTN
Looking Beyond VOO? These 3 BlackRock ETFs Offer 20%+ Upside in 2026
Premium
Market News
Looking Beyond VOO? These 3 BlackRock ETFs Offer 20%+ Upside in 2026
26d ago
BLK
IBB
Vertex Pharmaceuticals price target raised to $615 from $607 at Barclays
PremiumThe Fly
Vertex Pharmaceuticals price target raised to $615 from $607 at Barclays
28d ago
VRTX
Vertex Pharmaceuticals announces Casgevy reimbursement agreement
PremiumThe Fly
Vertex Pharmaceuticals announces Casgevy reimbursement agreement
28d ago
VRTX
Vertex Pharmaceuticals price target raised to $616 from $612 at Morgan Stanley
PremiumThe Fly
Vertex Pharmaceuticals price target raised to $616 from $612 at Morgan Stanley
30d ago
VRTX
Vertex Pharmaceuticals price target raised to $543 from $541 at RBC Capital
PremiumThe Fly
Vertex Pharmaceuticals price target raised to $543 from $541 at RBC Capital
30d ago
VRTX
Analyst Maintains Hold on Vertex as Strong CF Franchise Offsets Mixed Q1 Results and Non‑CF Pipeline Uncertainty
PremiumRatingsAnalyst Maintains Hold on Vertex as Strong CF Franchise Offsets Mixed Q1 Results and Non‑CF Pipeline Uncertainty
30d ago
VRTX
Vertex Pharmaceuticals price target lowered to $436 from $437 at Canaccord
Premium
The Fly
Vertex Pharmaceuticals price target lowered to $436 from $437 at Canaccord
30d ago
VRTX
Vertex Pharmaceuticals price target lowered to $572 from $577 at Bernstein
Premium
The Fly
Vertex Pharmaceuticals price target lowered to $572 from $577 at Bernstein
30d ago
SION
VRTX
Vertex Pharmaceuticals Earnings Call Highlights New Growth Engines
PremiumCompany Announcements
Vertex Pharmaceuticals Earnings Call Highlights New Growth Engines
1M ago
VRTX
Closing Bell Movers: Pinterest jumps 15% on earnings beat; Palantir slips
PremiumThe Fly
Closing Bell Movers: Pinterest jumps 15% on earnings beat; Palantir slips
1M ago
FN
ON
Moderna updates on Cystic Fibrosis collaboration with Vertex Pharmaceuticals
PremiumThe Fly
Moderna updates on Cystic Fibrosis collaboration with Vertex Pharmaceuticals
1M ago
MRNA
VRTX
Vertex Pharmaceuticals reports Q1 EPS $4.02, consensus $4.31
PremiumThe Fly
Vertex Pharmaceuticals reports Q1 EPS $4.02, consensus $4.31
1M ago
VRTX
Vertex Pharmaceuticals affirms FY26 revenue $12.95B-$13.1B, consensus $13.05B
PremiumThe FlyVertex Pharmaceuticals affirms FY26 revenue $12.95B-$13.1B, consensus $13.05B
1M ago
VRTX
Vertex options imply 5.5% move in share price post-earnings
Premium
The Fly
Vertex options imply 5.5% move in share price post-earnings
1M ago
VRTX
Notable companies reporting after market close
Premium
The Fly
Notable companies reporting after market close
1M ago
ON
PGR

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >